Buscar
Mostrando ítems 51-60 de 1509
Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments
(Informa Healthcare, 2012-09-01)
Introduction: Rheumatic fever (RF), a systemic illness that may occur following Group A beta-hemolytic streptococcal (GABHS) pharyngitis in children, is a major problem in countries with limited resources. Because of its ...
Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments
(Informa Healthcare, 2012-09-01)
Introduction: Rheumatic fever (RF), a systemic illness that may occur following Group A beta-hemolytic streptococcal (GABHS) pharyngitis in children, is a major problem in countries with limited resources. Because of its ...
Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
(Biomedicines, 2020-08-23)
Since we have gained an understanding of the immunological pathophysiology of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, treatment based on biological drugs has become a fundamental ...
Prevalence of musculoskeletal manifestations in the adult Brazilian population: a study using COPCORD questionnaires
(Clinical & Exper Rheumatology, 2009-01-01)
ObjectiveTo estimate the prevalence of musculoskeletal manifestations in the population of Vitoria, Brazil, using the COPCORD questionnaire.MethodsThis was a cross-sectional study of 578 people with an age range of 18-65. ...
Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
(Faculdade de Medicina / USP, 2011)
OBJECTIVE: Immunosuppressed patients are at risk of microsporidiosis, and this parasitosis has an increased rate of dissemination in this population. Our objective was to evaluate the presence of microsporidiosis and other ...
Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments
(Informa Healthcare, 2014)